# Azithromycin for Child Survival in Niger: Mortality and Resistance Trial

> **NCT04224987** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 864493 (actual)

## Conditions studied

- Mortality
- Resistance Bacterial
- Child, Only

## Interventions

- **DRUG:** Azithromycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04224987
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-24
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 864493 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224987, "Azithromycin for Child Survival in Niger: Mortality and Resistance Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04224987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*